Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peter Burbelo and Jeffrey Cohen.
Peter Burbelo
Connection Strength
2.279
Jeffrey Cohen
  1. Reinfection With SARS-CoV-2: Implications for Vaccines. Clin Infect Dis. 2021 12 06; 73(11):e4223-e4228.
    View in: PubMed
    Score: 0.983
  2. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. J Infect Dis. 2020 06 29; 222(2):206-213.
    View in: PubMed
    Score: 0.890
  3. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31).
    View in: PubMed
    Score: 0.060
  4. Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency. J Clin Immunol. 2021 08; 41(6):1146-1153.
    View in: PubMed
    Score: 0.059
  5. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell. 2021 04 01; 184(7):1836-1857.e22.
    View in: PubMed
    Score: 0.058
  6. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
    View in: PubMed
    Score: 0.058
  7. In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Pediatric Infect Dis Soc. 2020 Dec 31; 9(6):769-771.
    View in: PubMed
    Score: 0.058
  8. SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein. Blood. 2020 12 17; 136(25):2905-2917.
    View in: PubMed
    Score: 0.057
  9. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.